Replies to post #66 on Immatics NV (IMTX)

[FACT-MASTER]

Confirmed here as well.

https://www.biospace.com/article/gsk-continues-to-thin-cell-therapy-pipeline-as-it-ends-partnership-with-immatics/

Do we know which checkpoint inhibitor IMTX was working with, with the IMA203 + checkpoint inhibitor trial?

[Solarfuture]

But it seems to be a strategic decision from GSK and has a least nothing to do with Immatics. Reading the news I feel confident Immatics will have success in the future and these levels of pps are history in the near future...At this stage the company is already much more worth....half of the marketcap do they in cash....